Therefore, compounds acting as inhibitors of cholinesterase could be considered as potential drugs in Alzheimer’s disease (AD) treatment, other neurological disorders and therapeutics [11,12,13,14,15]. This evidence concerns the gene BCHE and Alzheimer disease.